20-31766608-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000300403.11(TPX2):c.282C>T(p.Ser94=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00203 in 1,613,472 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 20 hom., cov: 30)
Exomes 𝑓: 0.0011 ( 31 hom. )
Consequence
TPX2
ENST00000300403.11 synonymous
ENST00000300403.11 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.74
Genes affected
TPX2 (HGNC:1249): (TPX2 microtubule nucleation factor) Enables importin-alpha family protein binding activity and protein kinase binding activity. Involved in activation of protein kinase activity; microtubule cytoskeleton organization; and negative regulation of microtubule depolymerization. Located in intercellular bridge; mitotic spindle; and nucleoplasm. Colocalizes with spindle pole. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 20-31766608-C-T is Benign according to our data. Variant chr20-31766608-C-T is described in ClinVar as [Benign]. Clinvar id is 785652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.74 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.011 (1677/151896) while in subpopulation AFR AF= 0.0387 (1601/41418). AF 95% confidence interval is 0.0371. There are 20 homozygotes in gnomad4. There are 776 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPX2 | NM_012112.5 | c.282C>T | p.Ser94= | synonymous_variant | 5/18 | ENST00000300403.11 | NP_036244.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPX2 | ENST00000300403.11 | c.282C>T | p.Ser94= | synonymous_variant | 5/18 | 1 | NM_012112.5 | ENSP00000300403 | P1 | |
TPX2 | ENST00000340513.4 | c.282C>T | p.Ser94= | synonymous_variant | 5/19 | 1 | ENSP00000341145 |
Frequencies
GnomAD3 genomes AF: 0.0110 AC: 1673AN: 151778Hom.: 20 Cov.: 30
GnomAD3 genomes
AF:
AC:
1673
AN:
151778
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00311 AC: 781AN: 251126Hom.: 18 AF XY: 0.00239 AC XY: 325AN XY: 135706
GnomAD3 exomes
AF:
AC:
781
AN:
251126
Hom.:
AF XY:
AC XY:
325
AN XY:
135706
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00109 AC: 1592AN: 1461576Hom.: 31 Cov.: 33 AF XY: 0.000926 AC XY: 673AN XY: 727078
GnomAD4 exome
AF:
AC:
1592
AN:
1461576
Hom.:
Cov.:
33
AF XY:
AC XY:
673
AN XY:
727078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0110 AC: 1677AN: 151896Hom.: 20 Cov.: 30 AF XY: 0.0105 AC XY: 776AN XY: 74236
GnomAD4 genome
AF:
AC:
1677
AN:
151896
Hom.:
Cov.:
30
AF XY:
AC XY:
776
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at